| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/26/2012 | WO2011154570A9 Ghrelin variant and uses thereof |
| 01/26/2012 | WO2011150517A3 Xyxin fragment biomarker for diagnosis of colon cancer |
| 01/26/2012 | WO2011143280A3 Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling |
| 01/26/2012 | WO2011119724A3 Colorimetric and fluorescent proteins |
| 01/26/2012 | WO2011115420A3 Adhesive extracellular matrix mimetic |
| 01/26/2012 | WO2011105841A9 Recombinant expression vector for expressing brazzein, and novel multiple mutation brazzein variant having greater sweetness |
| 01/26/2012 | WO2011097527A3 Immunoprotection of therapeutic moieties using enhanced fc regions |
| 01/26/2012 | WO2011057871A3 Use of a protein homologous to a meab protein for increasing the enzymatic activity of a 3-hydroxycarboxylic acid-coa mutase |
| 01/26/2012 | US20120023603 Brassica Plant Comprising a Mutant Indehiscent Allele |
| 01/26/2012 | US20120022500 Compositions and Methods for Induced Brown Fat Differentiation |
| 01/26/2012 | US20120022239 Precipitation of biomolecules with negatively charged polymers |
| 01/26/2012 | US20120022236 Recombinant Anti-VLA4 Antibody Molecules |
| 01/26/2012 | US20120022235 Promoter molecules for use in plants |
| 01/26/2012 | US20120022234 Method for the purification of albumin conjugates |
| 01/26/2012 | US20120022233 Collagen implant |
| 01/26/2012 | US20120022232 Cells for increased protein expression comprising one or more release factors and methods of use |
| 01/26/2012 | US20120022136 Cellular Genes Regulated by HIV-1 Infection and Methods of Use Thereof |
| 01/26/2012 | US20120022006 B-lymphocyte stimulator binding polypeptides and methods based thereon |
| 01/26/2012 | US20120022005 Synthetic Dragline Spider Silk-Like Proteins |
| 01/26/2012 | US20120022000 Use of a peptide in the treatment or prevention of metastasis |
| 01/26/2012 | US20120021999 Pro-apoptotic peptides |
| 01/26/2012 | US20120021995 Polypeptides that Bind TRAIL-R1 and TRAIL-R2 |
| 01/26/2012 | US20120021993 Protein scaffold library based on kringle domain structure and uses thereof |
| 01/26/2012 | US20120021987 Mucin 3 EGF-Like Domains |
| 01/26/2012 | US20120021985 Albumin fusion proteins |
| 01/26/2012 | US20120021984 Glycoprotein Hormone Analogs |
| 01/26/2012 | US20120021974 Novel inhibitor of angiogenesis |
| 01/26/2012 | US20120021971 Functional Food Product Comprising Heat Shock Protein or a Hydrolysate Thereof |
| 01/26/2012 | US20120021530 HETEROGENEOUS FOLDAMERS CONTAINING alpha, beta, and/or gamma-AMINO ACIDS |
| 01/26/2012 | US20120021518 Growth factor homolog zvegf4 |
| 01/26/2012 | US20120021437 Tetranor-pgdm/pgjm specific immunogens, antibodies, tracers, assay kits and methods for making same |
| 01/26/2012 | US20120021432 Phosphorylated NF45 Biomarkers, Antibodies And Methods Of Using Same |
| 01/26/2012 | US20120021425 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 01/26/2012 | US20120021050 Nanoparticle formulated glycolipid antigens for immunotherapy |
| 01/26/2012 | US20120021006 Egfr-homing double-stranded rna vector for systemic cancer treatment |
| 01/26/2012 | US20120021002 Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof |
| 01/26/2012 | US20120020997 Multi plasmid system for the production of influenza virus |
| 01/26/2012 | US20120020992 Production of Biologically Active Proteins |
| 01/26/2012 | US20120020990 Isolated mammalian monocyte cell genes; related reagents |
| 01/26/2012 | US20120020977 Pancreatic cancer genes |
| 01/26/2012 | US20120020973 Chimeric ospa genes, proteins, and methods of use thereof |
| 01/26/2012 | US20120020957 Dengue virus neutralizing antibodies and use thereof |
| 01/26/2012 | US20120020919 Methods for treating viral infection using il-28 and il-29 |
| 01/26/2012 | US20120020918 Il-1 family variants |
| 01/26/2012 | US20120020911 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
| 01/26/2012 | US20120020890 Staphylococcus aureus proteins and nucleic acids |
| 01/26/2012 | US20120020888 Biomarker |
| 01/26/2012 | US20120020882 Peptide-based compounds |
| 01/26/2012 | DE112009001927T5 Pflanzen mit gesteigerter ertragsbezogenen Eigenschaften und Verfahren zu deren Herstellung Plants having enhanced yield-related traits and processes for their preparation |
| 01/26/2012 | DE112009001560T5 Planzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben Planzen having enhanced yield-related traits and methods of making the same |
| 01/26/2012 | DE102006029620B4 Neue stress-assoziierte Genprodukte aus Fragilariopsis cylindrus New stress-associated gene products from Fragilariopsis cylindrus |
| 01/26/2012 | CA2806645A1 Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma |
| 01/26/2012 | CA2806166A1 Intracellular immunity |
| 01/26/2012 | CA2805794A1 Signal biomarkers |
| 01/26/2012 | CA2805442A1 Methods and compositions for modification of an hla locus |
| 01/26/2012 | CA2804998A1 Peptide compounds for regulating the complement system |
| 01/26/2012 | CA2803137A1 Plant cytochrome p450 |
| 01/26/2012 | CA2768866A1 High yield yellow fever virus strain with increased propagation in cells |
| 01/25/2012 | EP2410337A1 Method for measuring -glucan, and -glucan-binding protein for use in the method |
| 01/25/2012 | EP2410060A1 Genes for modifying plant traits IV |
| 01/25/2012 | EP2410059A2 Plants overexpressing Golden2-like protein (GLK) having enhanced yield-related traits and a method for making the same |
| 01/25/2012 | EP2410058A1 Modification of flavonoid biosynthesis in plants with transparent testa 2 |
| 01/25/2012 | EP2410057A1 Modification of flavonoid biosynthesis in plants with transparent testa 8 |
| 01/25/2012 | EP2410056A1 Modification of flavonoid biosynthesis in plants with transparent testa glabra 1 |
| 01/25/2012 | EP2410055A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| 01/25/2012 | EP2409992A1 A human anti-tumor necrosis factor alpha monoclonal antibody and use thereof |
| 01/25/2012 | EP2409988A2 Peptide fragments for inducing synthesis of extracellular matrix proteins |
| 01/25/2012 | EP2409987A1 Ribosomal P protein complex from Plasmodium falciparum as antigen against malaria |
| 01/25/2012 | EP2409986A1 Invention related to flocculation of yeast cells |
| 01/25/2012 | EP2409711A1 Enzyme treatment of foodstuffs for celiac sprue |
| 01/25/2012 | EP2409707A1 Polymer-based sustained release device |
| 01/25/2012 | EP2409569A2 Method for administering GLP-1 molecules |
| 01/25/2012 | EP2408926A2 Production of recombinant proteins in ciliates and uses thereof |
| 01/25/2012 | EP2408913A1 Neil3 peptides and vaccines including the same |
| 01/25/2012 | EP2408912A1 Foxm1 peptides and vaccines containing the same |
| 01/25/2012 | EP2408812A1 Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions |
| 01/25/2012 | EP2408811A1 Methods and compositions for modulating cardiac contractility |
| 01/25/2012 | EP2408810A2 Determination of interactions of constant parts of antibodies with fc-gamma receptors |
| 01/25/2012 | EP2408809A1 Peptides modulating the activity of igf-1 and the applications of said peptides |
| 01/25/2012 | EP2408808A1 Terminally-functionalized conjugates and uses thereof |
| 01/25/2012 | EP2408807A2 Method for therapeutic use |
| 01/25/2012 | EP2408806A1 Analogs of temporin-sha, and uses thereof |
| 01/25/2012 | EP2408805A2 Fungal cutinase from magnaporthe grisea |
| 01/25/2012 | EP2408804A1 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases |
| 01/25/2012 | EP2408475A1 Flagellin fusion proteins and use thereof to induce immune responses against pseudomonas aeruginosa |
| 01/25/2012 | EP2408474A2 Compositions and methods for blood-brain barrier delivery of igg-decoy receptor fusion proteins |
| 01/25/2012 | EP2408470A1 Soluble non-depot insulin conjugates and uses thereof |
| 01/25/2012 | EP2408468A2 USE OF NKp46 FOR PREVENTING DIABETES |
| 01/25/2012 | EP2408464A2 Hcv-derived polypeptides and uses thereof |
| 01/25/2012 | EP2208734B1 Food material for inhibiting the formation of osteoclast |
| 01/25/2012 | EP2144623B1 Process for the manufacture of a dairy-based anti-inflammatory composition |
| 01/25/2012 | EP2069395B1 Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma |
| 01/25/2012 | EP1945760B1 Productivity augmenting protein factor, novel cell lines and uses thereof |
| 01/25/2012 | EP1904635B1 Glycosylated il-7, preparation and uses |
| 01/25/2012 | EP1836314B1 Modified human growth hormone |
| 01/25/2012 | EP1639113B1 Methods and means for delaying seed shattering in plants |
| 01/25/2012 | EP1532167B1 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
| 01/25/2012 | EP1440157B1 Methods and means for producing proteins with predetermined post-translational modifications |
| 01/25/2012 | EP1412379B1 Vaccine |
| 01/25/2012 | EP1355918B9 Recombinant protective protein from $i(streptococcus pneumoniae) |